Home
Brands & Services
Early Access Programs
CRO services
Data collection
Independant committees
Market Access & HEOR
Medicine acceptability
Quality assurance
Safety reporting
Statistics & Medical writing
About us
Meet our team
History & values
Compliance
Resources
ClinSearch News
cd cs Testimonials
Publications
Careers
Privacy Policy
Legal Notice
Cookies Policy
Contact

Connect with us

Market Access & HEOR

Resources

Senior Scientific Director
Health economist
Biostatisticians
Epidemiologist

Description

This department provides decision tools to help decision-makers in their choice between different health strategies related to drugs, medical devices, or diagnostic tests. The interdisciplinary team helps manufacturers collect the relevant clinical and health economic data for obtaining a fair price and reimbursement for their innovation in major European markets.

We also support manufacturers in communicating the value of new products to multiple stakeholders, though an all-encompassing view of clinical efficacy, real-world data, and opportunity costs of various intervention mixes, budget impact, and cost-effectiveness models.

Our solutions

Pricing & Reimbursement
Submissions to HTA agencies
Clinical evidence vs. Economic Models
Budget impact analysis
Analytic modelling & decision-making
Micro-costing analyses
Handling of national databases
Systematic review and meta-analyses

Day-to-day activity

Pricing & Reimbursement dossiers
Submissions to HTA agencies
Modeling (Markov, Microsimulation, DES, etc.)
Multi-Criteria Decision-Analysis, Decision Tree Analysis, etc.
Database handling (PMSI, NHS, etc.)
Network meta-analysis